Mills Theresa A, Kawji Mazen M, Cataldo Vinceent D, Pappas Nicholas D, O'Meallie Lawrence P, Breaux Darrin M, Glancy D Luke
Department of Medicine, Louisiana State University Health Sciences Center, New Orleans, USA.
J La State Med Soc. 2004 Nov-Dec;156(6):327-31.
Both beta-adrenergic receptor antagonist drugs (beta-blockers) and non-dihydropyridine calcium-channel blockers (non-DHP CCBs), ie, diltiazem and verapamil, can cause sinus arrest or severe sinus bradycardia, and when drugs from the two classes are used together, these effects may be more than additive. We report nine patients in whom a beta-blocker (one patient), a non-DHP CCB (one patient), or the combination (seven patients) caused sinus arrest or severe sinus bradycardia which resulted in hospitalization in six of the nine. Although this combination of drugs always has the potential for causing profound bradycardia, certain aspects of the history, such as age, the presence of renal or hepatic disease, and the number and types of other medications, are further predictors of marked bradycardia with hypotension.
β-肾上腺素能受体拮抗剂药物(β受体阻滞剂)和非二氢吡啶类钙通道阻滞剂(非二氢吡啶CCB),即地尔硫䓬和维拉帕米,均可导致窦性停搏或严重窦性心动过缓,当这两类药物联合使用时,这些效应可能会超过相加作用。我们报告了9例患者,其中1例使用β受体阻滞剂、1例使用非二氢吡啶CCB、7例联合使用这两类药物后发生窦性停搏或严重窦性心动过缓,9例中有6例因此住院。尽管这种药物组合始终有导致严重心动过缓的可能性,但病史中的某些方面,如年龄、肾或肝疾病的存在以及其他药物的数量和类型,是发生伴有低血压的显著心动过缓的进一步预测因素。